中文 | English
Return
Total: 457 , 1/46
Show Home Prev Next End page: GO
Author:(GONG HAO)

1.Quality analysis of Pinghuo tea standard decoction

Xinmei ZHAO ; Hongyang SANG ; Chunjing YANG ; Jingwei LEI ; Haiyan GONG ; Caixia XIE ; Chunya ZHANG ; Haohan DUAN ; Hao YU

China Pharmacy 2025;36(1):71-78

2.Research advances on traditional Chinese medicine monomers and compounds intervening in ankylosing spondy-litis-related signaling pathways

Haidong ZHOU ; Yaohong LU ; Liangshen HU ; Li GONG ; Maohua LIN ; Shipeng HAO ; Jianbin YAN ; Weihui CHEN ; Shaoyong FAN

China Pharmacy 2025;36(3):373-378

3.Competitive Immunoassay for Detection of Enrofloxacin Based on Metasurface Plasma Resonance Chip Coupled with Gold Nanoparticles

Wei-Hao JI ; Hong-Li FAN ; Lei GONG ; Li-Ping HUANG ; Xiao-Long FAN ; Jia-Yong HU ; Tao-Hong ZHOU ; Gang LIU

Chinese Journal of Analytical Chemistry 2025;53(5):814-822

4.Jianpi Qinghua Formula improves metabolic-associated fatty liver disease by modulating PGC1α/PPARα/CPT1A pathway.

Yan-Yan XIAO ; Xu HAN ; Qing-Guang CHEN ; Jun-Fei XU ; Chi CHEN ; Fan GONG ; Hao LU

China Journal of Chinese Materia Medica 2025;50(9):2505-2514

5.Comparative study on effectiveness of double reverse traction reduction versus open reduction internal fixation in treating complex tibial plateau fractures.

Hao LIU ; Zhihao LIN ; Yueyan MA ; Haifeng GONG ; Tianrui WANG ; Fagang YE ; Yanling HU

Chinese Journal of Reparative and Reconstructive Surgery 2025;39(7):795-800

6.Effectiveness of Acupuncture in Improving Quality of Life for Patients with Advanced Cancer: A Systematic Review and Meta-Analysis.

Xin YU ; Si-Yao GONG ; Qin LUO ; Gui-Xing XU ; Hao TIAN ; Qian LI ; Ming CHEN ; Sha YANG ; Shu-Guang YU

Chinese journal of integrative medicine 2025;31(4):360-371

7."Weibing" in traditional Chinese medicine-biological basis and mathematical representation of disease-susceptible state.

Wanyang SUN ; Rong WANG ; Shuhua OUYANG ; Wanli LIANG ; Junwei DUAN ; Wenyong GONG ; Lianting HU ; Xiujuan CHEN ; Yifang LI ; Hiroshi KURIHARA ; Xinsheng YAO ; Hao GAO ; Rongrong HE

Acta Pharmaceutica Sinica B 2025;15(5):2363-2371

8.Advancements in CRISPR/Cas systems for disease treatment.

Yangsong XU ; Hao LE ; Qinjie WU ; Ning WANG ; Changyang GONG

Acta Pharmaceutica Sinica B 2025;15(6):2818-2844

9.A dual-targeting peptide-drug conjugate based on CXCR4 and FOLR1 inhibits triple-negative breast cancer.

Kun WANG ; Cong WANG ; Hange YANG ; Gong CHEN ; Ke WANG ; Peihong JI ; Xudong SUN ; Xuegong FAN ; Jie MA ; Zhencun CUI ; Xingkai WANG ; Hao TIAN ; Dengfu WU ; Lu WANG ; Zhimin WANG ; Jiangyan LIU ; Juan YI ; Kuan HU ; Hailong ZHANG ; Rui WANG

Acta Pharmaceutica Sinica B 2025;15(10):4995-5009

10.Impact of Minimally Invasive Extracorporeal Circulation on Systemic Inflammatory Response and Transfusion Requirements after Coronary Artery Bypass Grafting

Xiaojuan ZHOU ; Libin YANG ; Peng YANG ; Hao GONG ; Xu YANG

Journal of Kunming Medical University 2025;46(3):58-65

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 457 , 1/46 Show Home Prev Next End page: GO